ORCHARD THERAPEUTICS PLC Accounts Receivable, Credit Loss Expense (Reversal)
ORCHARD THERAPEUTICS PLC reported Accounts Receivable, Credit Loss Expense (Reversal) of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC accounts receivable, credit loss expense (reversal) for the quarter ending 2023-09-30 was $0.00.
- ORCHARD THERAPEUTICS PLC accounts receivable, credit loss expense (reversal) for the quarter ending 2023-06-30 was $0.00.
- ORCHARD THERAPEUTICS PLC accounts receivable, credit loss expense (reversal) for the quarter ending 2023-03-31 was $0.00.
- ORCHARD THERAPEUTICS PLC accounts receivable, credit loss expense (reversal) for fiscal 2022 was $0.00.
- ORCHARD THERAPEUTICS PLC accounts receivable, credit loss expense (reversal) for fiscal 2021 was $0.00.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-03-14 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-14 |